Screening for hepatitis B protein in bowel disease tissue
Part of Cancer, Digestive system clinical trials.
This study looks for a specific protein (hepatitis B virus X) in tissue samples from patients with certain bowel conditions. It aims to see if this protein might be linked to cancer growth, which could help with early detection or treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with colitis-associated cancer, colorectal cancer, diverticulitis, ischemic colitis, or Crohn's disease
- You had an endoscopic biopsy or surgical removal of tissue between 2021 and 2024
- You have no history of hepatitis B infection
- You have signed consent for using your clinical data in research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
This study uses a simple blood test to monitor tiny pieces of tumor DNA (ctDNA) in people with colorectal cancer that spread to the liver or with liver cancer (HCC), before and after liver surgery or transplant. It aims to help doctors detect cancer return earlier and guide treatment.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
Hear when a new Colitis-associated Colorectal Cancer (CAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.